274 related articles for article (PubMed ID: 12061873)
1. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain.
Du X; Guo C; Hansell E; Doyle PS; Caffrey CR; Holler TP; McKerrow JH; Cohen FE
J Med Chem; 2002 Jun; 45(13):2695-707. PubMed ID: 12061873
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
[TBL] [Abstract][Full Text] [Related]
3. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of macrocyclic trypanosomal cysteine protease inhibitors.
Chen YT; Lira R; Hansell E; McKerrow JH; Roush WR
Bioorg Med Chem Lett; 2008 Nov; 18(22):5860-3. PubMed ID: 18585034
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
[TBL] [Abstract][Full Text] [Related]
9. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
[TBL] [Abstract][Full Text] [Related]
10. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
[TBL] [Abstract][Full Text] [Related]
11. Divergent modes of enzyme inhibition in a homologous structure-activity series.
Ferreira RS; Bryant C; Ang KK; McKerrow JH; Shoichet BK; Renslo AR
J Med Chem; 2009 Aug; 52(16):5005-8. PubMed ID: 19637873
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach.
de Souza ML; de Oliveira Rezende Junior C; Ferreira RS; Espinoza Chávez RM; Ferreira LLG; Slafer BW; Magalhães LG; Krogh R; Oliva G; Cruz FC; Dias LC; Andricopulo AD
J Chem Inf Model; 2020 Feb; 60(2):1028-1041. PubMed ID: 31765144
[TBL] [Abstract][Full Text] [Related]
13. Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents.
Caputto ME; Fabian LE; Benítez D; Merlino A; Ríos N; Cerecetto H; Moltrasio GY; Moglioni AG; González M; Finkielsztein LM
Bioorg Med Chem; 2011 Nov; 19(22):6818-26. PubMed ID: 22000947
[TBL] [Abstract][Full Text] [Related]
14. Aryl ureas represent a new class of anti-trypanosomal agents.
Du X; Hansell E; Engel JC; Caffrey CR; Cohen FE; McKerrow JH
Chem Biol; 2000 Sep; 7(9):733-42. PubMed ID: 10980453
[TBL] [Abstract][Full Text] [Related]
15. Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors.
Burtoloso AC; de Albuquerque S; Furber M; Gomes JC; Gonçalez C; Kenny PW; Leitão A; Montanari CA; Quilles JC; Ribeiro JF; Rocha JR
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005343. PubMed ID: 28222138
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
Ferreira RS; Dessoy MA; Pauli I; Souza ML; Krogh R; Sales AI; Oliva G; Dias LC; Andricopulo AD
J Med Chem; 2014 Mar; 57(6):2380-92. PubMed ID: 24533839
[TBL] [Abstract][Full Text] [Related]
18. Novel cruzain inhibitors for the treatment of Chagas' disease.
Rogers KE; Keränen H; Durrant JD; Ratnam J; Doak A; Arkin MR; McCammon JA
Chem Biol Drug Des; 2012 Sep; 80(3):398-405. PubMed ID: 22613098
[TBL] [Abstract][Full Text] [Related]
19. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
[TBL] [Abstract][Full Text] [Related]
20. Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors.
Avelar LA; Camilo CD; de Albuquerque S; Fernandes WB; Gonçalez C; Kenny PW; Leitão A; McKerrow JH; Montanari CA; Orozco EV; Ribeiro JF; Rocha JR; Rosini F; Saidel ME
PLoS Negl Trop Dis; 2015; 9(7):e0003916. PubMed ID: 26173110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
